Elsevier

Clinics in Dermatology

Volume 15, Issue 2, March–April 1997, Pages 199-206
Clinics in Dermatology

Papillomavirus and HPV typing

https://doi.org/10.1016/S0738-081X(96)00164-2Get rights and content

First page preview

First page preview
Click to open first page preview

References (83)

  • E Ahlfors et al.

    The odontogenic keratocysts: a benign cystic tumor?

    J Oral Maxillofac Surg

    (1984)
  • M.A. Kahn

    Demonstration of human papillomavirus DNA in a peripheral ameloblastoma by in situ hybridization

    Hum Pathol

    (1992)
  • L Gissmann et al.

    Human papillomaviruses (HPV): Characterization of four different isolates

    Virology

    (1977)
  • B.B. Barr et al.

    Human papillomavirus infection and skin cancer in renal allograft recipients

    Lancet

    (1989)
  • M Kawashima et al.

    Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses

    J Invest Dermatol

    (1990)
  • S Obalek et al.

    Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV 3 or HPV 3-related types in immunosuppressed patients

    J Invest Dermatol

    (1992)
  • L.M. de Jong-Tieben et al.

    High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients

    J Invest Dermatol

    (1995)
  • H Delius et al.

    Primer-directed sequencing of human papillomavirus types

    Curr Top Microbiol Immunol

    (1994)
  • H-U Bernard et al.

    Evolution of papillomaviruses

    Curr Top Microbiol Immunol

    (1994)
  • E-M de Villiers

    Human pathogenic papillomavirus types: An update

    Curr Top Microbiol Immunol

    (1994)
  • T Matsukura et al.

    Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions

    Int J Cancer

    (1995)
  • A Schneider et al.

    Prevalence of human papillomavirus genomes in tissues from the lower genital tract as detected by molecular in situ hybridization

    Int J Gynecol Pathol

    (1991)
  • G.J. Nuovo et al.

    Occurrence of multiple types of human papillomavirus in genital tract lesions. Analysis by in situ hybridization and the polymerase chain reaction

    Am J Pathol

    (1991)
  • R.K. Saiki et al.

    Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

    Science

    (1989)
  • M.M. Manos et al.

    The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses

    Cancer Cells Mol Diagnost Hum Cancer

    (1989)
  • A.J.C. van den Brule et al.

    Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction

    J Clin Microbiol

    (1990)
  • H.L. Smits et al.

    Detection and typing of human papillomaviruses present in fixed and stained archival cervical smears by a consensus polymerase chain reaction and direct sequence analysis allow the identification of a broad spectrum of human papillomavirus types

    J Gen Virol

    (1992)
  • M.T.E. Cornelissen et al.

    Localization of human papillomavirus type 16 DNA using the polymerase chain reaction in the cervix uteri of women with cervical intraepithelial neoplasia

    J Gen Virol

    (1989)
  • Y Fujinaga et al.

    Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction

    J Gen Virol

    (1991)
  • O Lungu et al.

    Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia

    JAMA

    (1992)
  • H Yoshikawa et al.

    Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers

    Jpn J Cancer Res

    (1991)
  • A.M. de Roda-Husman et al.

    The use of general primers GP5 and GP6 elongated at their 3′ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR

    J Gen Virol

    (1995)
  • N Ylitalo et al.

    Detection of genital human papillomavirus by single-tube nested PCR and type-specific oligonucleotide hybridization

    J Clin Microbiol

    (1995)
  • J.C. Zitz et al.

    Restriction fragment length polymorphism analysis of isotope-labeled polymerase chain reaction-amplified human papillomavirus DNA combines sensitivity with built-in contamination detection

    Mod Pathol

    (1994)
  • M.V. Jacobs et al.

    Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes

    J Clin Microbiol

    (1995)
  • H.U. Bernard et al.

    Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorthms

    J Infect Dis

    (1994)
  • C.K. Ong et al.

    Identification of genomic sequences of three novel human papillomavirus sequences in cervical smears of Amazonian Indians

    J Infect Dis

    (1994)
  • C.L. Peyton et al.

    Identification of five novel papillomavirus sequences in the new Mexico triethnic population

    J Infect Dis

    (1994)
  • C.L. Peyton et al.

    A novel human papillomavirus sequences from an international cervical cancer study

    J Infect Dis

    (1994)
  • M.M. Manos et al.

    Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses

    J Infect Dis

    (1994)
  • Cited by (105)

    • The human papillomavirus18 E7 protein inhibits CENP-C binding to α-satellite DNA

      2015, Virus Research
      Citation Excerpt :

      Infection with human papillomaviruses (HPVs) is linked to the pathogenesis of a variety of human diseases, most notably cervical cancer, a disease that is responsible for the death of over 250,000 women per year worldwide (de Villiers, 1997; Parkin et al., 2005).

    • Cutaneous effects of BRAF inhibitor therapy: A case series

      2013, Annals of Oncology
      Citation Excerpt :

      With mounting evidence that BRAF inhibitors activate the MAPK pathway in cells that lack a BRAF mutation [26–28], the SCCs that present precipitously with BRAF-inhibitor therapies are likely driven by this pathway in some manner. In addition, an unrelated anti-trypanosomal drug, suramin, inhibits RAF and has resulted in SCC and KA as well [20–31]. Interestingly, prior studies of the multikinase inhibitor sorafenib report that SCC occurs in 6–7% of patients at a median time of 6.7 months [32].

    • The role of HPV type in Recurrent Respiratory Papillomatosis

      2010, International Journal of Pediatric Otorhinolaryngology
    View all citing articles on Scopus
    View full text